Texas Neurological Society

Did you know that TNS is the nation's largest state neurological society? 🧠 With the Winter meeting coming up it’s the perfect time to invite a neuro colleague to join the TNS! Share with other #TexasNeuros to get involved! https://bit.ly/3NCRk0J

TNS President Michael Soileau, MD FAAN, joined Power for Parkinson's Executive Director Dr. Nina Mosier to discuss emerging treatments for PD. 🚨 Watch here: https://lnkd.in/d7rJfBRh

The long-awaited results of the Exenatide-PD3 study have finally been presented. In this crucially important phase 3 study, 194 participants were randomised to receive either #exenatide (a drug from the #GLP1 agonist class that stems originally from the diabetes field, and which has been repurposed for use as a possible disease modifying treatment for people with #Parkinson disease) or placebo. To everyone's regret, there was no difference between the two study arms, neither for the primary outcome nor for any of the other outcome measures. This is very disappointing, particularly because two out of three earlier phase 2 studies with GLP-1 agonist (one also with exenatide) did point to a possible disease modifying effect. The research team and the sponsors are to be commended for sharing these findings with the trial participants first, before anybody else would hear. I think that most of us would agree that disappointing as this may be, this basically puts an end to the hopes that drugs from the GLP1 agonist class might become the first pharmacotherapeutic approach to slow down the progression of Parkinson's. The study was exceptionally well designed, and to my mind serves as a model for future studies that will test other pharmacological as well as nonpharmacological strategies (including our own STEPWISE and Slow-SPEED trials where we test the disease modifying effects of #exercise). https://lnkd.in/eazAmZVr Cure Parkinson's Simon Stott Parkinson's Foundation The Michael J. Fox Foundation for Parkinson's Research Van Andel Institute

🧠 World Stroke Day is a crucial time to raise awareness about recognizing the signs of stroke. Share these F.A.S.T. (R.Á.P.I.D.O.) warning signs with your patients and community—early intervention can save lives. These infographics are simple ways to spread the word and educate those around us about stroke prevention. Swipe for both English and Spanish versions to reach as many people as possible. Let’s help our communities be prepared! El tratamiento rápido salva vidas!💪 https://bit.ly/2MYVFwA #WorldStrokeDay #StrokeAwareness #FAST #StrokePrevention #DerrameCerebral #RÁPIDO #PrevenciónDeDerrames

Winter is coming...the TNS Winter Conference, that is! 🧠 We're just a few months away from the Annual Winter Conference. Mark your calendars now and we hope you'll join us in Austin from Jan 30-Feb 2! #TNSW2025

🚑 Let's make Texas the national leader in stroke care! 🧠 Mobile Stroke Units (MSUs) bring stroke care directly to patients, offering rapid on-site treatment and extending the reach of specialized stroke centers. By ensuring that critical interventions happen within the first hour of a stroke, MSUs are improving survival rates and reducing stroke-related disability in rural and underserved communities. The expansion of MSUs across rural Texas means fewer delays, more lives saved, and better recovery outcomes. Together, we can make stroke care accessible for all Texans. 💪 Learn more: https://bit.ly/3NCp0vE

Its a great day! Congrats to all of our patients, teams, and colleagues for all of their hard work on this important study. We finally have approval! U.S. FDA Approves VYALEV™ (foscarbidopa and foslevodopa) for Adults Living with Advanced Parkinson's Disease

Mark your calendars! TNS is heading to the Texas Capitol on April 1st for TNS Lobby Day. More info to come! 🥼🩺 https://bit.ly/3U3o46U #TXlege

Happy #PAweek! #PAsGoBeyond at every step of the healthcare experience, from diagnosis to prescription to ongoing monitoring and treatment. Let's celebrate all of the awesome PAs who have committed their time and energy to the #neuro field! 🧠🙌

🧠📣 This one is for all the neurological advanced practice registered nurses and physician assistants! Have you seen the AAN's APP resource center? Check out the AAN’s ever-growing toolbox for educational and networking opportunities. https://bit.ly/3ThPKmz